These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3061347)

  • 1. Microglia express MHC class II in normal and demyelinating human white matter.
    Hayes GM; Woodroofe MN; Cuzner ML
    Ann N Y Acad Sci; 1988; 540():501-3. PubMed ID: 3061347
    [No Abstract]   [Full Text] [Related]  

  • 2. Microglia are the major cell type expressing MHC class II in human white matter.
    Hayes GM; Woodroofe MN; Cuzner ML
    J Neurol Sci; 1987 Aug; 80(1):25-37. PubMed ID: 3302117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
    van der Maesen K; Hinojoza JR; Sobel RA
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules.
    Gehrmann J; Banati RB; Kreutzberg GW
    J Neuroimmunol; 1993; 48(2):189-98. PubMed ID: 8227316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.
    Tooyama I; Kimura H; Akiyama H; McGeer PL
    Brain Res; 1990 Jul; 523(2):273-80. PubMed ID: 2400911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions.
    Bö L; Mörk S; Kong PA; Nyland H; Pardo CA; Trapp BD
    J Neuroimmunol; 1994 May; 51(2):135-46. PubMed ID: 8182113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune response in multiple sclerosis plaques.
    Boyle EA; McGeer PL
    Am J Pathol; 1990 Sep; 137(3):575-84. PubMed ID: 1698025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
    Hauser SL; Bhan AK; Gilles F; Kemp M; Kerr C; Weiner HL
    Ann Neurol; 1986 Jun; 19(6):578-87. PubMed ID: 3524414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages, microglial cells, and HLA-DR antigens in fetal and infant brain.
    Esiri MM; al Izzi MS; Reading MC
    J Clin Pathol; 1991 Feb; 44(2):102-6. PubMed ID: 1864982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR antigens in multiple sclerosis: two-dimensional gel electrophoresis.
    Sriram S; Stewart GJ; Buhler M; Grumet C; Engleman E
    Neurology; 1985 Feb; 35(2):248-51. PubMed ID: 3855504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis.
    Washington R; Burton J; Todd RF; Newman W; Dragovic L; Dore-Duffy P
    Ann Neurol; 1994 Jan; 35(1):89-97. PubMed ID: 7506877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell infiltration and expression of MHC class II antigen by macrophages and microglia in a heterogeneous group in leukoencephalopathy.
    Tomimoto H; Akiguchi I; Akiyama H; Kimura J; Yanagihara T
    Am J Pathol; 1993 Aug; 143(2):579-86. PubMed ID: 8102032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.
    Mattiace LA; Davies P; Dickson DW
    Am J Pathol; 1990 May; 136(5):1101-14. PubMed ID: 1693471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor identified in multiple sclerosis brain.
    Hofman FM; Hinton DR; Johnson K; Merrill JE
    J Exp Med; 1989 Aug; 170(2):607-12. PubMed ID: 2754393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of HLA-DR reactive microglia in Alzheimer's disease.
    McGeer PL; Itagaki S; Tago H; McGeer EG
    Ann N Y Acad Sci; 1988; 540():319-23. PubMed ID: 3061340
    [No Abstract]   [Full Text] [Related]  

  • 18. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage populations associated with multiple sclerosis plaques.
    Esiri MM; Reading MC
    Neuropathol Appl Neurobiol; 1987; 13(6):451-65. PubMed ID: 3328828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
    Schütt C; Horejsi V; Walzel H; Siegl E
    Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.